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teenager who left Bolivia 14 years ago. 
Ventricular neurocysticercosis in an adopted 
An otherwise healthy 15-year-old male was transferred 
from another hospital to our institution on March 28, 
1997, because of the rapid onset of signs compatible 
with increased intracranial pressure (ICP) and the 
presence of hydrocephalus on a computerized tomo- 
graphy (CT) scan of the head. He had been adopted 
from Bolivia in 1983 and had not left Western Europe 
nor had close contacts with individuals from developing 
countries during this time period. Two months earlier, 
he had suffered from spontaneously resolving headache, 
fever, nausea, and vomiting that had been attributed to 
a viral meningitis (sterile CSF with transient lympho- 
cytic pleiocytosis and elevated proteins). On admission 
to our hospital, magnetic resonance imaging (MRI) 
revealed a solitary 1.5 cm round cystic lesion in the left 
lateral ventricle that was not visible on the CT. It was 
attached to the choroid plexus and obstructed CSF 
circulation (see figure). Because of clinical deterior- 
ation, the patient rapidly underwent surgical ventricu- 
lostomy for drainage and removal of the cyst. Histology 
established the diagnosis. 
QUESTIONS 
1. What is the diagnosis? 
2. What other methods of diagnosis are available? 
3. What are the usual clinical features of this disease? 
4. What are the possibilities for treatment? 
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Stained sections of the cyst revealed a scolex 
consistent with Cysticercus cellulosae. The diagnosis is 
ventricular neurocysticercosis. 
Despite a low sensitivity in cases with single paren- 
chymatous cysts, serodiagnosis by immunoblot may 
be positive, both in serum and CSF, in more than 
80% of patients with meningeal irritation and intra- 
ventricular cysts, thus providing a helpful diagnostic 
tool in conjunction with MRI. 
Though intraventricular cysts may be present in up 
to one third of patients with active neurocysticercosis, 
they coexist most often with parenchymatous cysts 
which may cause seizures, the most common symp- 
tom at presentation (70%). Headache (8%) and 
symptoms of hydrocephalus (5%) are more rare. 
As stated by Cuetter et al., the current treatment 
standards for ventricular neurocysticercosis imply 
either a ventriculoperitoneal shunt or a temporary 
ventriculostomy when increased ICP due to hydro- 
cephalus occurs. Surgical removal of the cysts must 
be performed if they are big, obstruct CSF flow, or 
complicate shunt functioning. In patients with intra- 
ventricular cysts without hydrocephalus, or with only 
slight dilatation of the ventricles, these authors favor 
first a trial of albendazole therapy alone, under close 
supervision (15 mg/kg/day given for two 15-day 
treatment courses, one month apart, initially with 
steroids). They otherwise combine this therapy with 
ventriculoperitoneal shunt. Three of four patients, 
however, who underwent a diversionary procedure 
in their series required repeated procedures because 
of obstruction of the shunt, a fact that could justify 
early surgical removal of the cyst when feasible. 
DISCUSSION 
Neurocysticercosis consists of infection of the central 
nervous system with the larval stage of Taenia solium, 
Cysticercus cellulosae. Whereas human intestinal infection 
with the tapeworm results from ingestion of under- 
cooked pork containing viable cysticerci, cysticercosis 
is acquired by ingestion of 'T: solium eggs from food, 
water or hands contaminated with feces of human 
carriers. Self-infection is possible via the fecal-oral 
route. The estimated median incubation period of this 
disease is 3.5 years. Neurocysticercosis has been virtudy 
eliminated from industrialized nations, but it still affects 
millions of people in the developing countries of Latin 
America, Asia, and Africa. Paralleling the increase in 
immigration of individuals from endemic areas, an 
increase in the prevalence of neurocysticercosis has 
been reported in the United States. 
This case presents several instructive features. It 
demonstrates first that neurocysticercosis may be a 
dreadful illness that should be suspected in immigrants 
from endemic areas in the world presenting with 
neurological signs or symptoms, even many years after 
they left their country. Indeed, the absence of contact 
with potential carriers of 'T: solium since his adoption, 
and the absence of proglottides or eggs on repeated 
stool analyses, strongly suggest that this patient acquired 
cysticercus at least 14 years earlier, before coming to 
Switzerland. Clinical manifestations probably occurred 
at the third of the four stages of neurocysticercosis, the 
colloid cyst stage that usually takes place 2 to 10 years 
after infection. This stage is characterized by the 
leakage of antigens through the cyst's deteriorating 
capsule, before it dies and calcifies. In case of ventricu- 
lar involvement, the resulting inflammatory response 
may cause ventriculitis and a localized reaction that 
fixes the cyst to the ventricular wall with thickening 
and secondary blockade of the CSF circulation. 
Ventricular neurocysticercosis alone, without paren- 
chymatous cysts, is rare and can be difficult to diagnose. 
Unlike the classical form of the disease, it usually does 
not present with seizures but rather causes increased 
ICP or less overt signs or symptoms including the 
aseptic meningitis with which our patient initially 
presented. Moreover, as illustrated also by this report, 
ventricular cysts may not be seen on CT. Specific 
antibodies were found in our patient's serum and CSF 
by ELISA and immunoblot (Tropeninstitut, Basel, 
Switzerland). 
The patient was discharged on June 14, after a short 
course of dexamethasone and initiation of albendazole 
for one month. Seven months later, his neurological 
signs and symptoms has resolved, the MRI showed no 
residual hydrocephalus or cyst, and serum antibodies 
had disappeared. 
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